Sinopharm Tech Holdings Limited (8156) Stock Statistics & Valuation Metrics

Sinopharm Tech Holdings Limited has a market cap or net worth of HKD 122.94M. The enterprise value is HKD 173.64M.

Market Cap

HKD 122.94M

Enterprise Value

HKD 173.64M

Sinopharm Tech Holdings Limited has 633,693,050 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

633,693,050

Owned by Insiders

―

Owned by Institutions

―

Sinopharm Tech Holdings Limited’s return on equity (ROE) is 0.20 and return on invested capital (ROIC) is 44.99%.

Return on Equity (ROE)

0.20

Return on Assets (ROA)

-0.41

Return on Invested Capital (ROIC)

44.99%

Return on Capital Employed (ROCE)

0.25

Revenue Per Employee

1.47M

Profits Per Employee

-294.90K

Employee Count

31

Asset Turnover

2.03

Inventory Turnover

331.87

The current PE Ratio of Sinopharm Tech Holdings Limited is -7.39. Sinopharm Tech Holdings Limited’s PEG ratio is -0.01.

PE Ratio

-7.39

PS Ratio

2.50

PB Ratio

-1.14

Price to FCF

-16.16

Price to Operating Cash Flow

-7.51

PEG Ratio

-0.01

In the last 12 months, Sinopharm Tech Holdings Limited had revenue of 45.58M and earned -9.14M in profits. Earnings per share was -0.02.

Revenue

45.58M

Gross Profit

6.42M

Operating Income

-8.17M

Pretax Income

-11.69M

Net Income

-9.14M

EBITDA

-6.94M

Earnings Per Share (EPS)

-0.02

In the last 12 months, operating cash flow was -7.06M and capital expenditures 0, giving a free cash flow of -7.06M billion.

Operating Cash Flow

-7.06M

Free Cash Flow

-7.06M

Free Cash Flow per Share

-0.02

Sinopharm Tech Holdings Limited pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-6.19%

Earnings Yield

-17.25%

Beta

0.32

52-Week Price Change

-36.39%

50-Day Moving Average

0.19

200-Day Moving Average

0.23

Relative Strength Index (RSI)

48.92

Average Volume (3m)

53.52K

Sinopharm Tech Holdings Limited upcoming earnings date is Mar 04, 2027, TBA (Not Confirmed).

Last Earnings Date

Sep 24, 2026

Next Earnings Date

Mar 04, 2027

Ex-Dividend Date

―

Sinopharm Tech Holdings Limited as a current ratio of 0.38, with Debt / Equity ratio of -66.22%

Current Ratio

0.38

Quick Ratio

0.38

Debt to Market Cap

0.33

Net Debt to EBITDA

-3.62

Interest Coverage Ratio

0.00

In the past 12 months, Sinopharm Tech Holdings Limited has paid 213.00K in taxes.

Income Tax

213.00K

Effective Tax Rate

-0.02

Sinopharm Tech Holdings Limited EV to EBITDA ratio is -21.43, with an EV/FCF ratio of -19.71.

EV to Sales

3.05

EV to EBITDA

-21.43

EV to Free Cash Flow

-19.71

EV to Operating Cash Flow

-19.71

Sinopharm Tech Holdings Limited has HKD 5.62M in cash and marketable securities with HKD 30.73M in debt, giving a net cash position of -HKD 25.11M billion.

Cash & Marketable Securities

HKD 5.62M

Total Debt

HKD 30.73M

Net Cash

-HKD 25.11M

Net Cash Per Share

-HKD 0.04

Tangible Book Value Per Share

-HKD 0.17

Gross margin is 14.09%, with operating margin of 0.00%, and net profit margin of -20.06%.

Gross Margin

14.09%

Operating Margin

0.00%

Pretax Margin

-25.65%

Net Profit Margin

-20.06%

EBITDA Margin

-14.25%

EBIT Margin

-17.91%

The average price target for Sinopharm Tech Holdings Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

-25.58%

EPS Growth Forecast

-12.50%

Smart Score

―

AI Score

45